Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1Phase 1/2 1

Status

Completed 841Recruiting 264Terminated 232Unknown 160Active not recruiting 138Withdrawn 77Not yet recruiting 65Suspended 16Enrolling by invitation 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

CNS 4Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Neoplasms 40Breast Neoplasms 38Prostatic Neoplasms 24Colorectal Neoplasms 23Uterine Cervical Neoplasms 16Carcinoma, Non-Small-Cell Lung 13Anxiety Disorders 13Stomach Neoplasms 9Lymphoma, Follicular 9Leukemia, Myeloid, Acute 9Carcinoma, Hepatocellular 9Brain Neoplasms 9Lung Neoplasms 8Head and Neck Neoplasms 8Urinary Bladder Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Esophageal Neoplasms 7Sarcoma 6Ovarian Neoplasms 6Esophageal Squamous Cell Carcinoma 6Depression 6Colonic Neoplasms 6Uterine Cervical Dysplasia 5Small Cell Lung Carcinoma 5Pain 5Glioma 5Epilepsy 5Dementia 5Cholangiocarcinoma 5Squamous Cell Carcinoma of Head and Neck 4

Interventions

Spinal Puncture 1Nivolumab 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Glioblastoma × Clear all
NCT07130149 2025-08-19

Sonodynamic-Chemoradiotherapy Integration in Glioblastoma

The First Affiliated Hospital of Zhengzhou University

Phase 2 Enrolling by invitation
230 enrolled
CNS

Glioblastoma

NCT06896110 2025-06-26

Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma

University of Iowa

Phase 1 Enrolling by invitation
34 enrolled
CNS

Astrocytoma, Glioblastoma

NCT06690216 2025-03-30

PD-L1-PET

Shandong Cancer Hospital and Institute

Phase 1/2 Enrolling by invitation
100 enrolled
CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma

NCT06616727 2024-09-27

The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM

Shanghai Simnova Biotechnology Co.,Ltd.

Phase 1 Enrolling by invitation
50 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡